Labcorp Holdings (LH) Liabilities and Shareholders Equity (2009 - 2026)

Labcorp Holdings has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $19.1 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 8.43% year-over-year to $19.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.8 billion (up 3.5% YoY) and the FY2025 annual result came in at $18.4 billion, changed 0.07% from the prior year.
• Liabilities and Shareholders Equity rose to $19.1 billion in Q1 2026 per LH's latest filing, from $18.4 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $20.7 billion in Q1 2022 and troughed at $16.5 billion in Q1 2024.
• A 5-year average of $18.5 billion and a median of $18.4 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The widest YoY moves for Liabilities and Shareholders Equity: up 10.22% in 2024, down 18.16% in 2024.
• Over 5 years, Liabilities and Shareholders Equity stood at $20.2 billion in 2022, then fell by 17.02% to $16.7 billion in 2023, then gained by 9.89% to $18.4 billion in 2024, then increased by 0.07% to $18.4 billion in 2025, then increased by 3.78% to $19.1 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $19.1 billion, $18.4 billion, and $18.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.